Advances in the prevention and treatment of cardiovascular disease (CVD) over the last decades have led to a marked reduction in mortality for CVD. Nevertheless, atherosclerosis leading to coronary artery disease and stroke remains one of the most common causes of death in the world. The usefulness of imaging tests in the early identification of disease led to identify subjects at major risk of poor outcomes, suggesting risk factor modification. The aim of this article is to analyze the state of art of combined imaging in patients at risk of CVD referred to MPI evaluation, to highlight the present and potential features able to provide incremental prognostic information to help clinicians in patient management and to reduce adverse events.
Combined evaluation of CAC score and myocardial perfusion imaging in patients at risk of cardiovascular disease: where are we and what do the data say / Mannarino, Teresa; D'Antonio, Adriana; Assante, Roberta; Zampella, Emilia; Gaudieri, Valeria; Petretta, Mario; Cuocolo, Alberto; Acampa, Wanda. - In: JOURNAL OF NUCLEAR CARDIOLOGY. - ISSN 1071-3581. - 30:6(2023), pp. 2349-2360. [10.1007/s12350-023-03288-2]
Combined evaluation of CAC score and myocardial perfusion imaging in patients at risk of cardiovascular disease: where are we and what do the data say
Mannarino, Teresa;D'Antonio, Adriana;Assante, Roberta;Zampella, Emilia;Gaudieri, Valeria;Petretta, Mario;Cuocolo, Alberto;Acampa, Wanda
2023
Abstract
Advances in the prevention and treatment of cardiovascular disease (CVD) over the last decades have led to a marked reduction in mortality for CVD. Nevertheless, atherosclerosis leading to coronary artery disease and stroke remains one of the most common causes of death in the world. The usefulness of imaging tests in the early identification of disease led to identify subjects at major risk of poor outcomes, suggesting risk factor modification. The aim of this article is to analyze the state of art of combined imaging in patients at risk of CVD referred to MPI evaluation, to highlight the present and potential features able to provide incremental prognostic information to help clinicians in patient management and to reduce adverse events.File | Dimensione | Formato | |
---|---|---|---|
Mannarino et al. J Nucl Cardiol (2023).pdf
accesso aperto
Descrizione: Articolo in rivista
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
799.22 kB
Formato
Adobe PDF
|
799.22 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.